HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minichromosome Maintenance Complex Component 6

A minichromosome maintenance protein that is a key component of the six member MCM protein complex. It is also found in tightly-bound trimeric complex with MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 4 and MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 7.
Also Known As:
DNA Replication Licensing Factor MCM6; MIS5 Homolog Protein; Homolog Protein, MIS5
Networked: 10 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Chen, Kai: 1 article (07/2021)
2. Cheng, Cheng: 1 article (07/2021)
3. Gu, Yaoyao: 1 article (07/2021)
4. Hu, Xiaoxiao: 1 article (07/2021)
5. Liu, Xiaowei: 1 article (07/2021)
6. Wu, Yeming: 1 article (07/2021)
7. Wu, Zhixiang: 1 article (07/2021)
8. Chen, Suixia: 1 article (07/2020)
9. Jia, Wenxian: 1 article (07/2020)
10. Li, Hongwen: 1 article (07/2020)

Related Diseases

1. Hepatocellular Carcinoma (Hepatoma)
2. Neoplasms (Cancer)
07/07/2021 - "Minichromosome maintenance complex component 6 (MCM6), as an important replication permission factor, is involved in the pathogenesis of various tumors. "
01/22/2018 - "Minichromosome maintenance complex component 6 (MCM6), which has been reported to up-regulate in multiple malignancies, was considered to be a novel diagnoses biomarker in HCC. "
01/01/2019 - "Cyclin-dependent kinase 5 regulatory subunit-associated protein 3 (CDK5RAP3) was identified as a tumor suppressor in gastric cancer, while, minichromosome maintenance complex component 6 (MCM6), which is closely related to the initiation of DNA replication, was reported to be upregulated in multiple malignancies. "
11/01/2014 - "Tumor protein 53 (TP53), TP63, Ki67, epidermal growth factor receptor (EGFR), minichromosome maintenance complex component 6 (MCM6), MCM7, uncharacterized proteins KIAA1522 and KIAA0317, and ubiquitin-protein ligase UHR1 (ICBP90) frequently presented high expression in bronchial brushing specimens from patients who had lung cancer compared with patients who had benign lung lesions. "
10/01/2015 - "The following genes appeared to be possibly related to the metastatic potential of the tumor: ELOVL fatty acid elongase 7 (ELOVL7), enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2), gastrulation brain homeobox 2 (GBX2), golgi membrane protein 1 (GOLM1), homeobox C6 (HOXC6), minichromosome maintenance complex component 6 (MCM6), marker of proliferation Ki-67 (MKI67), mucin 1, cell surface associated (MUC1), MYC binding protein 2, E3 ubiquitin protein ligase (MYCBP2), somatostatin receptor 1 (SSTR1), topoisomerase (DNA) II alpha 170 kDa (TOP2A) and exportin 6 (XPO6). "
3. Carcinogenesis
4. Stomach Neoplasms (Stomach Cancer)
5. Silicosis

Related Drugs and Biologics

1. Proteins (Proteins, Gene)
2. Messenger RNA (mRNA)
3. Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
4. Biomarkers (Surrogate Marker)
5. DNA (Deoxyribonucleic Acid)
6. ErbB Receptors (EGF Receptor)
7. Minichromosome Maintenance Complex Component 7
8. Polycomb Repressive Complex 2
9. Cyclin B2
10. Cyclin-Dependent Kinase 5